BVF Inc’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-11,668,473
| Closed | -$2.23M | – | 44 |
|
|
2025
Q3 | $2.23M | Buy |
11,668,473
+2,919,844
| +33% | +$3.5M | 0.09% | 42 |
|
|
2025
Q2 | $14.9M | Hold |
8,748,629
| – | – | 0.53% | 29 |
|
|
2025
Q1 | $13.8M | Hold |
8,748,629
| – | – | 0.56% | 29 |
|
|
2024
Q4 | $15.7M | Hold |
8,748,629
| – | – | 0.53% | 31 |
|
|
2024
Q3 | $53M | Hold |
8,748,629
| – | – | 1.55% | 19 |
|
|
2024
Q2 | $46M | Hold |
8,748,629
| – | – | 1.29% | 24 |
|
|
2024
Q1 | $74.3M | Hold |
8,748,629
| – | – | 2.04% | 15 |
|
|
2023
Q4 | $57.7M | Hold |
8,748,629
| – | – | 1.45% | 20 |
|
|
2023
Q3 | $27M | Hold |
8,748,629
| – | – | 0.73% | 30 |
|
|
2023
Q2 | $23.6M | Hold |
8,748,629
| – | – | 0.66% | 31 |
|
|
2023
Q1 | $26M | Hold |
8,748,629
| – | – | 0.95% | 34 |
|
|
2022
Q4 | $22M | Hold |
8,748,629
| – | – | 0.93% | 34 |
|
|
2022
Q3 | $15.9M | Buy |
8,748,629
+5,050,000
| +137% | +$13.3M | 0.66% | 46 |
|
|
2022
Q2 | $11.7M | Buy |
3,698,629
+3,000
| +0.1% | +$16.8K | 0.56% | 46 |
|
|
2022
Q1 | $22.8M | Buy |
3,695,629
+844,168
| +30% | +$7.42M | 0.91% | 33 |
|
|
2021
Q4 | $40.5M | Hold |
2,851,461
| – | – | 1.47% | 21 |
|
|
2021
Q3 | $22.8M | Buy |
2,851,461
+399,900
| +16% | +$6.36M | 0.89% | 32 |
|
|
2021
Q2 | $70M | Sell |
2,451,561
-456,765
| -16% | -$13.3M | 2.63% | 12 |
|
|
2021
Q1 | $84.5M | Sell |
2,908,326
-796,963
| -22% | -$18.5M | 3.17% | 11 |
|
|
2020
Q4 | $44.2M | Buy |
3,705,289
+699,700
| +23% | +$4.93M | 1.74% | 19 |
|
|
2020
Q3 | $20.7M | Buy |
3,005,589
+1,020,700
| +51% | +$6.93M | 1.13% | 31 |
|
|
2020
Q2 | $12.3M | Sell |
1,984,889
-435,676
| -18% | -$2.07M | 0.76% | 36 |
|
|
2020
Q1 | $9.68M | Sell |
2,420,565
-220,000
| -8% | -$1.11M | 0.9% | 27 |
|
|
2019
Q4 | $14.5M | Hold |
2,640,565
| – | – | 1.1% | 24 |
|
|
2019
Q3 | $8.9M | Buy |
2,640,565
+1,310,865
| +99% | +$3.24M | 0.94% | 31 |
|
|
2019
Q2 | $3.08M | Buy |
1,329,700
+749,332
| +129% | +$1.85M | 0.34% | 47 |
|
|
2019
Q1 | $1.99M | Hold |
580,368
| – | – | 0.22% | 50 |
|
|
2018
Q4 | $1.22M | Buy |
580,368
+3,597
| +0.6% | +$10.5K | 0.16% | 50 |
|
|
2018
Q3 | $1.73M | Buy |
576,771
+23,980
| +4% | +$80.2K | 0.15% | 54 |
|
|
2018
Q2 | $2.09M | Buy |
552,791
+43,609
| +9% | +$163K | 0.2% | 47 |
|
|
2018
Q1 | $1.94M | Buy |
+509,182
| New | +$2.12M | 0.2% | 41 |
|
BVF Inc's EPIX Position: Q4 2025 in Review
BVF Inc sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 11,668,473 shares — an estimated $2.23M sold.
BVF Inc first reported a position in EPIX in Q1 2018 and held it in 31 quarters. The position peaked at $84.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- BVF Inc reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- BVF Inc sold 11,668,473 ESSA Pharma shares in Q4 2025, an estimated $2.23M.
- BVF Inc first reported a position in ESSA Pharma in Q1 2018 and held it in 31 quarters.
- BVF Inc's ESSA Pharma position peaked at $84.5M in Q1 2021.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on BVF Inc's 13F filing for Q4 2025, filed 17 Feb 2026.